Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M70,590Revenue $M20,247Net Margin (%)10.8Z-Score3.8
Enterprise Value $M74,088EPS $1.5Operating Margin %13.1F-Score7
P/E(ttm))31.2Cash Flow Per Share $6.7Pre-tax Margin (%)12.7Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %-3.0Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %-19.5Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %10.3ROA % (ttm)5.4Higher Current Ratio y-yN
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)9.8Less Shares Outstanding y-yY
Payout Ratio %79.0Shares Outstanding M1,509ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTMason Hawkins 2014-12-31 Reduce-0.79%$39.99 - $46.37
($43.58)
$ 46.787%Reduce -28.08%8,977,941
ABTGeorge Soros 2014-12-31 Reduce-0.06%$39.99 - $46.37
($43.62)
$ 46.787%Reduce -24.46%602,181
ABTRay Dalio 2014-12-31 Buy 0.02%$39.99 - $46.37
($43.58)
$ 46.787%New holding45,000
ABTMario Gabelli 2014-12-31 Reduce-0.01%$39.99 - $46.37
($43.58)
$ 46.787%Reduce -33.96%65,337
ABTMason Hawkins 2014-09-30 Reduce-0.26%$41.05 - $43.69
($42.33)
$ 46.7810%Reduce -8.80%12,483,566
ABTMario Gabelli 2014-09-30 Reduce-0.01%$41.05 - $43.69
($42.33)
$ 46.7810%Reduce -38.44%98,937
ABTRay Dalio 2014-09-30 Sold Out -0.01%$41.05 - $43.69
($42.33)
$ 46.7810%Sold Out0
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 46.7816%New holding1,665,688
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 46.7816%Reduce -23.73%932,181
ABTRichard Pzena 2014-03-31 Add0.11%$35.85 - $40.12
($38.5)
$ 46.7818%Add 7.90%6,934,282
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 46.7818%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 46.7818%New holding17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 46.7818%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 46.7821%New holding3,250,000
ABTRobert Olstein 2013-12-31 Add0.19%$33.01 - $38.71
($36.89)
$ 46.7821%Add 23.45%179,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 46.7821%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 46.7821%Sold Out0
ABTRichard Pzena 2013-09-30 Add0.46%$32.93 - $36.88
($35.12)
$ 46.7825%Add 49.22%6,449,283
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 46.7825%Add 36.90%16,188,865
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 46.7825%Reduce -4.79%13,727,856
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Warmuth Michael JExecutive Vice President 2015-03-10Sell13,500$46.410.19view
Contreras JaimeSenior Vice President 2015-03-02Sell9,209$47.34-1.77view
Pavee Jean-YvesSenior Vice President 2015-03-02Sell652$47.48-2.06view
Contreras JaimeSenior Vice President 2015-02-18Sell423$46.260.52view
Pavee Jean-YvesSenior Vice President 2015-02-17Sell621$46.410.19view
ALLEN HUBERT LExecutive Vice President 2015-02-17Sell172$46.380.26view
Simhambhatla Murthy VSenior Vice President 2015-02-17Sell172$46.410.19view
CAPEK JOHN MExecutive Vice President 2015-02-04Sell34,292$45.661.84view
CAPEK JOHN MExecutive Vice President 2015-02-04Sell38,773$45.761.62view
CAPEK JOHN MExecutive Vice President 2015-02-04Sell9,935$45.831.46view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    AbbVie’s Q4 Reflects Its Tremendous Growth Potential Going Forward Feb 04 2015 
    What Could Be The Major Highlights In AbbVie’s Upcoming Earnings Call? Jan 29 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Diamond Hill Adds Two Companies to Portfolio in Third Quarter Dec 11 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Top 7 Dividend Aristocrats: The Best of The Best Dec 10 2014 
    6 Stocks Giving Investors Potential Dividend Hikes In December Dec 04 2014 
    Dividend Aristocrats In Focus Part 45: AbbVie Nov 24 2014 


    More From Other Websites
    Potential billion-dollar verdict rests on disputed deadline Mar 26 2015
    Potential billion-dollar verdict rests on disputed deadline Mar 26 2015
    Billion-dollar verdict rests on disputed missed deadline Mar 26 2015
    Billion-dollar verdict rests on disputed missed deadline Mar 26 2015
    MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook Mar 26 2015
    Buyback blackout Mar 24 2015
    Pioneering Bay Area med device entrepreneur dies in Thailand accident Mar 23 2015
    Viking Global Exited Its Position in AbbVie Mar 20 2015
    Sucampo Pharmaceuticals Revamp Impresses Wall Street Mar 17 2015
    Pharma Stock Outlook: Let's Make a Deal - Industry Outlook Mar 17 2015
    Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews Mar 17 2015
    Kentucky joins lawsuit against Omnicare, claiming billions in losses Mar 17 2015
    Top 2nd-half trades: Disney & health care Mar 16 2015
    Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States Mar 15 2015
    Why investor flows in high-grade bond funds rose Mar 13 2015
    This Health Care Dividend Stock Will Take Advantage of Emerging Market Growth Mar 13 2015
    Eminence Capital Sells Position in Allergan Mar 13 2015
    High-grade corporate bonds hit highest issuance Mar 12 2015
    Sale Rumor, Drugs Launch Boost High-Rated Mylan Stock Mar 11 2015
    Rising U.S. Dollar Could Help Federal Reserve Delay Rate Hike Mar 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK